Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 46.70%-3.29M | 242.87%3.37M | 12.87%-1.49M | -571.02%-1.92M | -78.65%-3.25M | 39.68%-6.17M | 4.40%-2.36M | 38.73%-1.71M | 89.22%-285.52K | 21.78%-1.82M |
Net income from continuing operations | 24.10%-6.18M | 89.43%-260.08K | 52.37%-966.41K | -10.60%-1.12M | -45.05%-3.84M | 24.00%-8.15M | -13.50%-2.46M | 28.30%-2.03M | 65.14%-1.01M | 6.06%-2.64M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | 154.85%169.5K | 318.37%69.66K | 321.11%70.12K | --12.51K | --17.2K |
Depreciation and amortization | 50.09%776.97K | 481.00%466.03K | -4.72%121.22K | -36.55%101.38K | -41.29%88.34K | -4.60%517.68K | -44.79%80.21K | -9.17%127.22K | 18.36%159.79K | 23.04%150.46K |
Other non cash items | 1,072.61%101.23K | -56.13%17.05K | 202.76%39.55K | 73.49%-19.3K | 3.09%63.93K | -109.31%-10.41K | 224.29%38.86K | -227.22%-38.49K | -195.93%-72.8K | 1,074.42%62.01K |
Change In working capital | 329.65%1.26M | 1,057.86%2.83M | -474.21%-1M | -317.16%-729.81K | -60.98%166.56K | 120.22%293.21K | 60.34%-295.05K | 62.15%-174.7K | 202.34%336.06K | 407.80%426.9K |
-Change in receivables | -214.69%-1.56M | -440.97%-443.25K | -17.72%-1.01M | -684.39%-820.91K | 111.04%718.68K | -1,144.58%-495.6K | 141.23%130K | -260.04%-861.47K | -131.78%-104.66K | 24.85%340.53K |
-Change in inventory | -262.55%-1.4M | 160.46%178.15K | -376.17%-757.14K | -196.86%-218.97K | -279.95%-597.09K | 36.65%-384.78K | -302.78%-294.68K | 37.93%-159.01K | 184.73%226.06K | 31.60%-157.15K |
-Change in prepaid assets | -668.27%-887.53K | -184.11%-272.57K | -10.76%-251.58K | -133.08%-370.27K | 112.87%6.9K | -151.42%-115.52K | 2,207.99%324.06K | -115.47%-227.15K | -132.57%-158.86K | 62.33%-53.58K |
-Change in payables and accrued expense | 182.88%4.93M | 973.28%2.83M | -18.62%930.72K | 101.73%1M | -61.42%164.45K | 344.80%1.74M | 27.57%-324.29K | 415.59%1.14M | 163.66%497.07K | 44.59%426.3K |
-Change in other current assets | 328.21%84.77K | --101.41K | 901.65%198.3K | ---- | ---- | 226.06%19.8K | --0 | 1,979,800.00%19.8K | ---- | ---- |
-Change in other current liabilities | -9.28%-503.54K | -26.76%-136.87K | -7.44%-129.31K | 0.96%-122.17K | -5.57%-115.19K | -13.28%-460.79K | 0.38%-107.97K | -16.69%-120.35K | -25.69%-123.36K | -12.37%-109.11K |
-Change in other working capital | 4,773.93%590.88K | 2,658.82%567.42K | -33.07%19.96K | 7,953.48%14.69K | 44.35%-11.18K | -164.31%-12.64K | -757.17%-22.18K | 44.77%29.81K | ---187 | -1,317.76%-20.09K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 46.70%-3.29M | 242.87%3.37M | 12.87%-1.49M | -571.02%-1.92M | -78.65%-3.25M | 39.68%-6.17M | 4.40%-2.36M | 38.73%-1.71M | 89.22%-285.52K | 21.78%-1.82M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 112.81%259.98K | -158.98%-1.35M | 314.78%2.83M | 178.64%2.33M | -7,757.52%-3.54M | -553.03%-2.03M | 67,882.92%2.29M | -22,831.05%-1.32M | -5,513.64%-2.96M | 81.88%-45.09K |
Net PPE purchase and sale | -832.77%-1.36M | -2,616.72%-860.25K | -492.88%-320.7K | -697.20%-119.37K | -32.66%-59.81K | -30.43%-145.82K | -835.45%-31.67K | -843.04%-54.09K | 71.64%-14.97K | 9.61%-45.09K |
Net investment purchase and sale | 186.00%1.62M | -121.19%-492.95K | 349.42%3.15M | 183.09%2.45M | ---3.48M | ---1.88M | --2.33M | ---1.26M | ---2.95M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 112.81%259.98K | -158.98%-1.35M | 314.78%2.83M | 178.64%2.33M | -7,757.52%-3.54M | -553.03%-2.03M | 67,882.92%2.29M | -22,831.05%-1.32M | -5,513.64%-2.96M | 81.88%-45.09K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 115.50%20.93M | 50,870,932.26%15.77M | -105.05%-199.5K | 0 | -7.11%5.36M | 2,477.48%9.71M | -99.99%31 | 3.95M | -8.15K | 5.77M |
Net common stock issuance | 109.52%20.37M | 409.05%15.77M | --0 | --0 | 24.02%4.6M | 2,479.64%9.72M | 722.04%3.1M | --2.92M | --0 | --3.71M |
Proceeds from stock option exercised by employees | --763.14K | --0 | --0 | --0 | -63.03%763.14K | --0 | ---3.1M | --1.03M | --0 | --2.06M |
Net other financing activities | -2,358.11%-199.5K | --0 | ---- | ---- | ---- | ---8.12K | --31 | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 115.50%20.93M | 50,870,932.26%15.77M | -105.05%-199.5K | --0 | -7.11%5.36M | 2,477.48%9.71M | -99.99%31 | --3.95M | ---8.15K | --5.77M |
Net cash flow | ||||||||||
Beginning cash position | 28.53%6.87M | 1.24%7M | -2.67%5.85M | -41.33%5.43M | 28.53%6.87M | -65.56%5.35M | -6.85%6.91M | -41.32%6.01M | -28.43%9.26M | -65.56%5.35M |
Current changes in cash | 1,084.71%17.9M | 29,127.05%17.78M | 23.07%1.13M | 112.73%414.71K | -136.47%-1.43M | 114.86%1.51M | 97.07%-61.26K | 132.78%919.39K | -20.60%-3.26M | 252.06%3.91M |
Effect of exchange rate changes | -286.05%-26.44K | -257.78%-32.85K | 244.45%20.11K | ---3.34K | -241.70%-10.36K | 229.97%14.21K | 24.71%20.82K | -21.75%-13.92K | --0 | 170.35%7.31K |
End cash Position | 260.16%24.75M | 260.16%24.75M | 1.24%7M | -2.67%5.85M | -41.33%5.43M | 28.53%6.87M | 28.53%6.87M | -6.85%6.91M | -41.32%6.01M | -28.43%9.26M |
Free cash flow | 26.41%-4.65M | 204.95%2.51M | -2.60%-1.81M | -577.31%-2.04M | -77.54%-3.31M | 38.92%-6.32M | 3.25%-2.39M | 36.93%-1.77M | 88.87%-300.5K | 21.53%-1.86M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |